PredictImmune
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
PredictImmune has raised €11M across 1 funding round from 2 investors, most recently a Series B round in Jul 2019. Based in Cambridge, UK; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€11M
€11,153,868
Funding rounds
1
Investors
2
distinct backers
Active since
2019-07
latest 2019-07
Funding by year
EUR raised per yearPredictImmune — funding by year — interactive chart.
Data table
| PredictImmune — funding by year | |
|---|---|
| 2019 | €11M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series B | €11M | Parkwalk Advisors,University of Cambridge Enterprise | View deal → |